Clinical Scorecard: BMP-2 Linked to Bone Consolidation in Revision THA
At a Glance
Category
Detail
Condition
Severe acetabular defects in revision total hip arthroplasty (THA)
Key Mechanisms
Bone morphogenetic protein-2 (BMP-2) augmentation promotes osteogenic activity to improve host bone stock and component support
Target Population
Patients undergoing revision THA with advanced acetabular defects, including Paprosky 3B classification and pelvic discontinuity
Care Setting
Tertiary referral center surgical setting
Key Highlights
83% of hips showed >50% radiographic bone consolidation at mean 76 months follow-up
Implant survivorship was 90% at 6 years and 70% at 10 years by all-cause reoperation; 90% survivorship at both time points when using acetabular loosening as endpoint
Postoperative complications occurred in 28% of hips, including infection (11%), dislocation (11%), and sciatic nerve palsy (6%)
Guideline-Based Recommendations
Diagnosis
Identify severe acetabular defects using Paprosky classification and assess pelvic discontinuity prior to revision THA
Management
Use layered surgical technique combining cancellous allograft bone chips, BMP-2 collagen sponge, and demineralized bone matrix for bone loss
Consider BMP-2 augmentation to enhance osteogenesis and bone consolidation in revision THA
Monitoring & Follow-up
Radiographic evaluation for bone consolidation postoperatively
Monitor for complications such as infection, dislocation, and nerve palsy
Assess implant survivorship using reoperation rates and acetabular loosening endpoints
Risks
Potential postoperative complications including infection, dislocation, and sciatic nerve palsy
Limited evidence due to retrospective design and small sample size
Patient & Prescribing Data
Patients with severe acetabular defects undergoing revision total hip arthroplasty
BMP-2 augmentation was associated with improved radiographic bone consolidation and midterm implant survivorship, though further studies are needed to confirm safety and efficacy
Clinical Best Practices
Employ a layered surgical approach combining allograft bone chips, BMP-2 collagen sponge, and demineralized bone matrix
Carefully select patients with advanced acetabular defects for BMP-2 augmentation
Conduct long-term follow-up with radiographic and clinical outcome assessments
Be vigilant for postoperative complications and manage promptly
Recognize current evidence limitations and consider multidisciplinary discussion before BMP-2 use
